NASDAQ:MASS 908 Devices (MASS) Stock Price, News & Analysis $2.56 -0.18 (-6.57%) (As of 11/22/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About 908 Devices Stock (NASDAQ:MASS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get 908 Devices alerts:Sign Up Key Stats Today's Range$2.55▼$2.7450-Day Range$2.34▼$3.9152-Week Range$2.19▼$12.51Volume210,506 shsAverage Volume367,700 shsMarket Capitalization$89.14 millionP/E RatioN/ADividend YieldN/APrice Target$8.00Consensus RatingModerate Buy Company Overview908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.Read More… Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. 908 Devices Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks52nd Percentile Overall ScoreMASS MarketRank™: 908 Devices scored higher than 52% of companies evaluated by MarketBeat, and ranked 515th out of 953 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus Rating908 Devices has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst Coverage908 Devices has only been the subject of 3 research reports in the past 90 days.Read more about 908 Devices' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for 908 Devices are expected to grow in the coming year, from ($1.75) to ($1.20) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of 908 Devices is -1.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of 908 Devices is -1.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share Ratio908 Devices has a P/B Ratio of 0.68. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about 908 Devices' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.69% of the float of 908 Devices has been sold short.Short Interest Ratio / Days to Cover908 Devices has a short interest ratio ("days to cover") of 8.3.Change versus previous monthShort interest in 908 Devices has recently increased by 5.84%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend Yield908 Devices does not currently pay a dividend.Dividend Growth908 Devices does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted5.69% of the float of 908 Devices has been sold short.Short Interest Ratio / Days to Cover908 Devices has a short interest ratio ("days to cover") of 8.3.Change versus previous monthShort interest in 908 Devices has recently increased by 5.84%, indicating that investor sentiment is decreasing significantly. News and Social Media1.7 / 5News Sentiment0.08 News Sentiment908 Devices has a news sentiment score of 0.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for 908 Devices this week, compared to 2 articles on an average week.MarketBeat Follows2 people have added 908 Devices to their MarketBeat watchlist in the last 30 days. Company Ownership3.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, 908 Devices insiders have not sold or bought any company stock.Percentage Held by Insiders27.70% of the stock of 908 Devices is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions88.06% of the stock of 908 Devices is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about 908 Devices' insider trading history. Receive MASS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 908 Devices and its competitors with MarketBeat's FREE daily newsletter. Email Address MASS Stock News Headlines908 Devices FY2024 EPS Forecast Lowered by Leerink PartnrsNovember 17, 2024 | americanbankingnews.com908 Devices FY2024 EPS Forecast Boosted by William BlairNovember 16, 2024 | americanbankingnews.comWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.November 23, 2024 | DTI (Ad)Leerink Partners Downgrades 908 Devices (MASS)November 14, 2024 | msn.comBoston firm to shift manufacturing to North CarolinaNovember 14, 2024 | bizjournals.com908 Devices Inc (MASS) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst ChallengesNovember 13, 2024 | finance.yahoo.com908 Devices downgraded to Market Perform from Outperform at LeerinkNovember 13, 2024 | markets.businessinsider.com908 Devices Inc. (NASDAQ:MASS) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | msn.comSee More Headlines MASS Stock Analysis - Frequently Asked Questions How have MASS shares performed this year? 908 Devices' stock was trading at $11.22 at the beginning of the year. Since then, MASS stock has decreased by 77.2% and is now trading at $2.56. View the best growth stocks for 2024 here. How were 908 Devices' earnings last quarter? 908 Devices Inc. (NASDAQ:MASS) posted its quarterly earnings data on Tuesday, April, 30th. The company reported ($0.33) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.36) by $0.03. 908 Devices's quarterly revenue was up 5.3% on a year-over-year basis. When did 908 Devices IPO? 908 Devices (MASS) raised $101 million in an IPO on Friday, December 18th 2020. The company issued 6,300,000 shares at $15.00-$17.00 per share. Cowen, SVB Leerink, Stifel and William Blair served as the underwriters for the IPO. Who are 908 Devices' major shareholders? Top institutional investors of 908 Devices include ARK Investment Management LLC (9.29%), Fred Alger Management LLC (2.37%), Geode Capital Management LLC (1.63%) and State Street Corp (1.38%). Insiders that own company stock include Christopher D Brown, Kevin J Knopp, Joseph H Iv Griffith, Trent A Basarsky, Mark Spoto, Michael S Turner and John Kenneweg. View institutional ownership trends. How do I buy shares of 908 Devices? Shares of MASS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of 908 Devices own? Based on aggregate information from My MarketBeat watchlists, some other companies that 908 Devices investors own include Meta Platforms (META), Tesla (TSLA), NVIDIA (NVDA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Visa (V). Company Calendar Last Earnings4/30/2024Today11/23/2024Fiscal Year End12/31/2024Next Earnings (Estimated)3/04/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Measuring & controlling devices, not elsewhere classified Sub-IndustryMeasuring And Control Equipment Current SymbolNASDAQ:MASS CUSIPN/A CIK1555279 Webwww.908devices.com Phone857-254-1500FaxN/AEmployees60Year FoundedN/APrice Target and Rating Average Stock Price Target$8.00 High Stock Price Target$14.00 Low Stock Price Target$4.00 Potential Upside/Downside+212.5%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($1.77) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-36,400,000.00 Net Margins-109.11% Pretax Margin-109.59% Return on Equity-24.60% Return on Assets-19.23% Debt Debt-to-Equity RatioN/A Current Ratio4.24 Quick Ratio3.54 Sales & Book Value Annual Sales$50.23 million Price / Sales1.77 Cash FlowN/A Price / Cash FlowN/A Book Value$3.76 per share Price / Book0.68Miscellaneous Outstanding Shares34,820,000Free Float25,177,000Market Cap$89.14 million OptionableOptionable Beta0.98 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report This page (NASDAQ:MASS) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 908 Devices Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 908 Devices With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.